Colorectal Screening Strategies in Underserved Populations
NCT ID: NCT05107661
Last Updated: 2023-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
62 participants
OBSERVATIONAL
2021-09-26
2023-08-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Rates of Colorectal Cancer Screening Among Never Screened Patients
NCT01742169
U01 CRC Project for Vietnamese Americans
NCT03413605
Trial of a Multilevel Intervention to Increase Colorectal Cancer Screening
NCT00836303
Increasing Colorectal Cancer Screening in African Americans
NCT00893295
Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population
NCT01385579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telephone Prompt
Following consent, the Research Team will call participants three times in the first month (within the first week of signing consent at week 2 and repeated at week 3) and then one time per month for the following two months with scripted messaging reminding the participant to complete the screening activity (colonoscopy or fecal test). Interpreter services via phone will be utilized for non-English speaking participants.
Telephone Prompt
Scripted messaging to remind subjects to complete their colorectal screening (colonoscopy or fecal test)
Digital Prompt
Following consent, scripted messaging will be sent three times in the first month (within the first week of signing consent at week 2 and repeated at week 3) and then once time per month for the following two months with scripted messaging reminding the participant to complete the screening activity (colonoscopy or fecal test). Digital prompts will be available in Spanish and English.
Telephone Prompt
Scripted messaging to remind subjects to complete their colorectal screening (colonoscopy or fecal test)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telephone Prompt
Scripted messaging to remind subjects to complete their colorectal screening (colonoscopy or fecal test)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 45-64 years of age
* Able to sign the informed consent form
* Meets eligibility criteria to participate in New Jersey Cancer Education Early Detection Community Outreach Program
* Uninsured/underinsured
* Household income \<250% Federal Poverty Level
* Must be New Jersy resident
* Must have Smart phone
* Must speak English or Spanish
Exclusion Criteria
* Individuals with Dementia
* ECOG Performance Status 3-4
* Prior Colonoscopy within past 10 years
45 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers University
OTHER
Virtua Health, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virtua Health
Voorhees Township, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-2021-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.